Faeth Therapeutics, Inc. (FTH) balance sheet
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$7.88−0.81 (-9.32%)
Close on Nov 20, 2026Market cap $203.62MP/E –Yield –
Faeth Therapeutics, Inc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -74.0%
Financial strength
- Current ratio
- 19.69
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 280.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.18
- Dividend yield
- –
See a number that looks wrong?